As in comparison to healthy people (Table 1), patients with COVID-19 had decreased lymphocyte (0.8 [IQR, 0.5–1.2] vs. 1.9 [IQR,1.3–2.2]; P < 0.001) and increased neutrophil-to-lymphocyte ratio (NLR) (5.5 [IQR, 2.3–14.3] vs. 1.9 [IQR, 1.2–2.9]; P < 0.001) and C-reactive protein (CRP) (24.3 [IQR, 9.4–51.2] vs. 5.7 [IQR, 1.1–7.9]; P < 0.001). The gene discussed is CRP; the disease is COVID-19.